Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119124773 | 11912477 | 3 | F | 20150317 | 20160622 | 20160113 | 20160701 | EXP | FR-ROCHE-1569040 | ROCHE | 75.53 | YR | F | Y | 0.00000 | 20160701 | MD | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119124773 | 11912477 | 1 | PS | Ranibizumab | RANIBIZUMAB | 1 | Other | LEFT EYE | U | 125156 | .5 | MG | |||||||
| 119124773 | 11912477 | 2 | SS | Ranibizumab | RANIBIZUMAB | 1 | Other | LEFT EYE | U | 125156 | .5 | MG | |||||||
| 119124773 | 11912477 | 3 | SS | Ranibizumab | RANIBIZUMAB | 1 | Other | LEFT EYE | U | 125156 | .5 | MG | |||||||
| 119124773 | 11912477 | 4 | SS | Ranibizumab | RANIBIZUMAB | 1 | Other | LEFT EYE | U | 125156 | .5 | MG | |||||||
| 119124773 | 11912477 | 5 | SS | Ranibizumab | RANIBIZUMAB | 1 | Other | RIGHT EYE | U | 125156 | .5 | MG | SOLUTION FOR INJECTION | ||||||
| 119124773 | 11912477 | 6 | SS | Ranibizumab | RANIBIZUMAB | 1 | Other | 0.5 MG, UNK | U | 125156 | .5 | MG | SOLUTION FOR INJECTION | ||||||
| 119124773 | 11912477 | 7 | SS | Ranibizumab | RANIBIZUMAB | 1 | Other | 0.5 MG, UNK | U | 125156 | .5 | MG | SOLUTION FOR INJECTION | ||||||
| 119124773 | 11912477 | 8 | SS | Ranibizumab | RANIBIZUMAB | 1 | Other | 0.5 MG, UNK | U | 125156 | .5 | MG | SOLUTION FOR INFUSION | ||||||
| 119124773 | 11912477 | 9 | SS | Ranibizumab | RANIBIZUMAB | 1 | Other | 0.5 MG IN RIGHT EYE | U | 125156 | .5 | MG | SOLUTION FOR INJECTION | ||||||
| 119124773 | 11912477 | 10 | SS | Ranibizumab | RANIBIZUMAB | 1 | Other | 0.5 MG IN RIGHT EYE | U | 125156 | .5 | MG | SOLUTION FOR INJECTION | ||||||
| 119124773 | 11912477 | 11 | SS | Ranibizumab | RANIBIZUMAB | 1 | Other | 0.5 MG IN RIGHT EYE | U | 125156 | .5 | MG | SOLUTION FOR INJECTION |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 119124773 | 11912477 | 1 | Diabetic retinal oedema |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 119124773 | 11912477 | HO |
| 119124773 | 11912477 | DS |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 119124773 | 11912477 | Coronary artery occlusion | |
| 119124773 | 11912477 | Inappropriate schedule of drug administration | |
| 119124773 | 11912477 | Nephrolithiasis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 119124773 | 11912477 | 1 | 20140417 | 0 | ||
| 119124773 | 11912477 | 2 | 20140522 | 0 | ||
| 119124773 | 11912477 | 3 | 20140619 | 0 | ||
| 119124773 | 11912477 | 4 | 20140717 | 0 | ||
| 119124773 | 11912477 | 5 | 20150212 | 0 | ||
| 119124773 | 11912477 | 6 | 201503 | 201503 | 0 | |
| 119124773 | 11912477 | 7 | 20150409 | 20150409 | 0 | |
| 119124773 | 11912477 | 8 | 201505 | 201505 | 0 | |
| 119124773 | 11912477 | 9 | 20150521 | 0 | ||
| 119124773 | 11912477 | 10 | 20160310 | 0 | ||
| 119124773 | 11912477 | 11 | 20160519 | 0 |